// App-Quantinova.ai

GW26-e1352 : Bivalirudin Versus Heparin Plus Glycoprotein IIb/IIIa Inhibitors in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: a Meta-Analysis of Randomized Controlled Trials

Researchers

Presenter

  • Jianbing Zhu

Principal Investigators

  • Junbo Ge

Medical Centers

  • Shanghai Institute of Cardiovascular Diseases, Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Acute Coronary Syndromes

  • Myocardial infarction

  • Venous thrombosis

Biomarkers

  • Glycosylphosphatidylinositol

Drug/Treatment

  • Bivalirudin

  • Heparin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved